Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 11/20 | 0.63 |
| ▸ | MAOB | P27338 | 10/20 | 0.58 |
| ▸ | MAOA | P21397 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7297436 | 0.82 | ACHE (0.62) | ACHEMAOBMAOAKDM4EALDH1A1 | |
| SCHEMBL7294583 | 0.80 | ACHE (0.66) | ACHEMAOBMAOA | |
| SCHEMBL5617972 | 0.78 | ACHE (1.00) | ACHEMAOBMAOA | |
| SCHEMBL7301020 | 0.78 | ACHE (0.65) | ACHEMAOBMAOA | |
| SCHEMBL7302273 | 0.78 | ACHE (0.70) | ACHEMAOBMAOA | |
| SCHEMBL7295186 | 0.77 | ACHE (0.62) | ACHEMAOBMAOAKDM4EALDH1A1 | |
| SCHEMBL7436425 | 0.77 | MAOB (0.82) | ACHEMAOBMAOA | |
| SCHEMBL7301896 | 0.76 | ACHE (0.67) | ACHEMAOBMAOA | |
| SCHEMBL5618254 | 0.76 | ACHE (0.77) | ACHEMAOBMAOAKDM4EALDH1A1 | |
| SCHEMBL7294525 | 0.75 | ACHE (0.59) | ACHEMAOBMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0363796-B1 | HETEROCYCLICALLY SUBSTITUTED ALKOXYCOUMARINES, METHOD FOR THEIR PREPARATION AND THERAPEUTICAL AGENTS CONTAINING SAME | BASF Aktiengesellschaft (DE) | 1993-08-11 | — | — | EP | disclosed |
| US-5227392-A | Monoamine oxidase inhibitors | BASF AKTIENGESELLSCHAFT (DE) | 1993-07-13 | — | — | US | disclosed |
| US-5073563-A | Enzyme inhibitors, CNS | BASF AKTIENGESELLSCHAFT (DE) | 1991-12-17 | — | — | US | disclosed |
| EP-0363796-A1 | Heterocyclically substituted alkoxycoumarines, method for their preparation and therapeutical agents containing same | BASF Aktiengesellschaft (DE) | 1990-04-18 | — | — | EP | disclosed |